Lantheus Holdings, Inc. (LNTH)

↓ Download CSV

CIK 0001521036 · Nasdaq · In Vitro & In Vivo Diagnostic Substances

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Lantheus Holdings, Inc. reported revenue of $1.54B, up 0.5% from the prior year. The company was profitable, with a net margin of 15.2% and a gross margin of 61.1%. It held $2.23B in total assets against $1.14B in total liabilities.

Key ratios (FY2025)

61.1%
Gross margin
20.2%
Operating margin
15.2%
Net margin
21.4%
Return on equity
+0.5%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$1.54B$1.53B$1.30B$935.06M$425.21M$339.41M$347.34M$343.37M$331.38M
Cost of Revenue$599.66M$545.62M$586.89M$353.36M$237.51M$200.65M$172.53M$168.49M$169.24M
Gross Profit$941.95M$988.29M$709.54M$581.70M$187.69M$138.76M$174.81M$174.88M$162.13M$137.78M
Operating Income$310.83M$456.98M$364.64M$36.20M-$60.83M-$4.20M$51.66M$64.49M$51.85M$56.59M
Net Income$233.56M$312.44M$326.66M$28.07M-$71.28M-$13.47M$31.67M$40.52M$123.39M
EPS (Diluted)$3.41$4.36$4.65$0.40$-1.06$-0.25$0.79$1.03$3.17$0.82
Total Assets$2.23B$1.98B$1.65B$1.32B$863.78M$869.82M$405.92M$439.83M$383.86M$255.90M
Total Liabilities$1.14B$892.33M$835.26M$874.11M$399.35M$355.62M$291.32M$368.83M$360.57M$362.41M
Shareholders' Equity$1.09B$1.09B$815.89M$447.15M$464.44M$514.21M$114.60M$71.00M$23.29M-$106.52M
Cash & Equivalents$359.12M$912.81M$713.66M$415.65M$98.51M$79.61M$92.92M$113.40M$76.29M$51.18M
Operating Cash Flow$390.14M$544.75M$305.26M$281.78M$53.92M$16.40M$80.38M$61.19M$54.78M$49.64M
Capital Expenditures$45.34M$260.00M$0$0$22.06M$20.13M$17.54M$7.40M
Shares Outstanding64.59M68.45M69.86M68.85M67.74M66.88M39.25M39.25M38.47M38.47M